ArticleHealth science reports2026
Research Trends and Insights of Charcot-Marie-Tooth Disease (CMT): A Visualization Analysis (2000-2025).
Article in Health science reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Article
- Genetic basis of Charcot-Marie-Tooth disease in Pakistani consanguineous families.Frontiers in neurology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background and Aims: The Charcot-Marie-Tooth disease (CMT) comprises genetically diverse motor and sensory neuropathies. This study aims to conduct a comprehensive investigation into the current academic and clinical status of CMT, thereby providing researchers with an extensive understanding of the research landscape and analysis of prevailing trends. Methods: We performed a comprehensive literature search on CMT from 2000 to 2025, using Web of Science Core Collection, employing bibliometric and visual analysis tools such as CiteSpace and VOSviewer. Results: The survey yielded 3115 records, showing a gradual annual publication increase. The USA, Italy, England, Germany, and France were the top five contributors. University of London (England) had the most publications (234). Assistance Publique Hopitaux Paris (France) and NSW Health (Australia) collaborated most with other institutions. Keywords analysis indicates primary research focuses: identifying novel gene variants, exploring disease progression markers, utilizing of animal models, investigating pathogenesis mechanisms of disease-causing genes, and advancing gene therapy. The three most cited articles investigated mitochondrial dysfunction's role in CMT pathogenesis. Conclusion: This study identifies three core research hotspots in CMT: establishing genotype-phenotype correlations, elucidating pathogenic mechanisms of causative genes, and developing molecular targeted therapies. The continuous refinement of disease biomarkers remains essential for guiding clinical trials.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.